Last reviewed · How we verify
Classical phenylketonuria
Approved treatments
- Tetrahydrobiopterin · University of Massachusetts, Worcester
- Kuvan · BioMarin
Kuvan works by activating the enzyme Phenylalanine Hydroxylase to break down phenylalanine. - Palynziq · Emory University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Classical phenylketonuria patent landscape — cliff calendar, originator estates, attackable patents
- Classical phenylketonuria treatment landscape brief
- Classical phenylketonuria treatment updates RSS
Frequently asked questions about Classical phenylketonuria
What drugs treat Classical phenylketonuria?
Tracked treatments include Tetrahydrobiopterin, Kuvan, Palynziq.
What is the treatment for Classical phenylketonuria?
Standard treatment for Classical phenylketonuria includes Tetrahydrobiopterin, Kuvan, Palynziq. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Classical phenylketonuria patent cliff · Classical phenylketonuria CI report
- Treatment: Tetrahydrobiopterin · University of Massachusetts, Worcester
- Treatment: Kuvan · BioMarin
- Treatment: Palynziq · Emory University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing